Position in CNTX
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$60,522
+$18,009 QoQ
Shares Held
23,100
-20.1% QoQ
Ownership
0.025%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#43
of 59 holders
Holding Since
Dec 2021
7 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in CNTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Virtu Financial LLC holds $48,923,071 across 139 Biotechnology names. CNTX ranks #88 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TERN |
Terns Pharmaceuticals, Inc.
|
70,715 | $3,728,094 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
7,634 | $3,408,886 | |
| 3 | CNTA |
Centessa Pharmaceuticals plc
|
67,775 | $2,692,023 | |
| 4 | APLS |
Apellis Pharmaceuticals, Inc.
|
54,785 | $2,204,000 | |
| 5 | BMRN |
Biomarin Pharmaceutical Inc
|
38,479 | $2,173,678 | |
| 6 | IBRX |
ImmunityBio, Inc.
|
262,298 | $2,011,825 | |
| 7 | ANAB |
Anaptysbio, Inc
|
33,323 | $1,848,093 | |
| 8 | ABVX |
Abivax S.A.
|
9,551 | $1,063,503 |
All Filings in CNTX
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $60,522 | 23,100 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $42,513 | 28,921 | Shares | Defined | 2026-02-23 | |
| 2024-12-31 | $12,219 | 11,638 | Shares | Defined | 2025-02-11 | |
| 2023-03-31 | $23,149 | 41,191 | Shares | Defined | 2023-05-01 | |
| 2022-12-31 | $37,460 | 57,455 | Shares | Defined | 2023-02-15 | |
| 2022-06-30 | $98,463 | 46,445 | Shares | Defined | 2022-08-09 | |
| 2021-12-31 | $142,365 | 53,521 | Shares | Defined | 2022-02-17 | |
| No filing history on record for this holder in this stock. | ||||||